| Dr Charles David Hill, MD | |
|
720 Medical Center Dr, West Point, MS 39773-9317 | |
| (662) 494-1620 | |
| (662) 494-0375 |
| Full Name | Dr Charles David Hill |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 720 Medical Center Dr, West Point, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346349131 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 17511 (Alabama) | Primary |
| Entity Name | Correct Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20040615000906 |
News Archive
American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.
When blood sugar levels in diabetes are poorly controlled, patients tend to have more complications such as depression and other mood disturbances, including anxiety and anger, and a lower overall quality of life.
The US Centers for Disease Control and Prevention (CDC) reported this week that in 2018 there are around 4.9 million American teenagers who are using tobacco in the form of cigarettes, e-cigarettes, cigars and hookahs.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 1 days ago
| Entity Name | Paragon Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20050218000756 |
News Archive
American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.
When blood sugar levels in diabetes are poorly controlled, patients tend to have more complications such as depression and other mood disturbances, including anxiety and anger, and a lower overall quality of life.
The US Centers for Disease Control and Prevention (CDC) reported this week that in 2018 there are around 4.9 million American teenagers who are using tobacco in the form of cigarettes, e-cigarettes, cigars and hookahs.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 1 days ago
| Entity Name | Pickens County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093069569 PECOS PAC ID: 3678708427 Enrollment ID: O20140109001299 |
News Archive
American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.
When blood sugar levels in diabetes are poorly controlled, patients tend to have more complications such as depression and other mood disturbances, including anxiety and anger, and a lower overall quality of life.
The US Centers for Disease Control and Prevention (CDC) reported this week that in 2018 there are around 4.9 million American teenagers who are using tobacco in the form of cigarettes, e-cigarettes, cigars and hookahs.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 1 days ago
| Entity Name | Relias Emergency Medicine Specialists Of Fayette Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093201543 PECOS PAC ID: 6800147604 Enrollment ID: O20180918001531 |
News Archive
American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.
When blood sugar levels in diabetes are poorly controlled, patients tend to have more complications such as depression and other mood disturbances, including anxiety and anger, and a lower overall quality of life.
The US Centers for Disease Control and Prevention (CDC) reported this week that in 2018 there are around 4.9 million American teenagers who are using tobacco in the form of cigarettes, e-cigarettes, cigars and hookahs.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 1 days ago
| Entity Name | Relias Emergency Medicine Specialists Of Hamilton, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457912297 PECOS PAC ID: 0547599490 Enrollment ID: O20190903001124 |
News Archive
American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.
When blood sugar levels in diabetes are poorly controlled, patients tend to have more complications such as depression and other mood disturbances, including anxiety and anger, and a lower overall quality of life.
The US Centers for Disease Control and Prevention (CDC) reported this week that in 2018 there are around 4.9 million American teenagers who are using tobacco in the form of cigarettes, e-cigarettes, cigars and hookahs.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 1 days ago
| Entity Name | Ess Of Eufaula, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013650456 PECOS PAC ID: 0840677456 Enrollment ID: O20220520001733 |
News Archive
American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.
When blood sugar levels in diabetes are poorly controlled, patients tend to have more complications such as depression and other mood disturbances, including anxiety and anger, and a lower overall quality of life.
The US Centers for Disease Control and Prevention (CDC) reported this week that in 2018 there are around 4.9 million American teenagers who are using tobacco in the form of cigarettes, e-cigarettes, cigars and hookahs.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles David Hill, MD 450 E President Ave, Tupelo, MS 38801-5599 Ph: (662) 377-4685 | Dr Charles David Hill, MD 720 Medical Center Dr, West Point, MS 39773-9317 Ph: (662) 494-1620 |
News Archive
American Express and TakePart announced today the final round of Members Project winners, chosen by the public through online voting. These five organizations will collectively receive $1 million in funding from American Express to advance their missions of serving communities around the country.
When blood sugar levels in diabetes are poorly controlled, patients tend to have more complications such as depression and other mood disturbances, including anxiety and anger, and a lower overall quality of life.
The US Centers for Disease Control and Prevention (CDC) reported this week that in 2018 there are around 4.9 million American teenagers who are using tobacco in the form of cigarettes, e-cigarettes, cigars and hookahs.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Berg Pharma, a Boston-based pharmaceutical company focused on discovery and development of new treatments in cancer and metabolic diseases, announced the initiation of a clinical trial entitled "Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 in Adult Patients Receiving Chemotherapy for the Treatment of Breast Cancer."
› Verified 1 days ago
Byron Watson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 720 Medical Center Dr, West Point, MS 39773 Phone: 662-494-1620 Fax: 662-494-0375 |